Pacific Edge Biotech trading halted after reaching a six year high
Dunedin-based DNA diagnostic test company Pacific Edge has had its shares on the NZX halted after they jumped to a six-year high.
Market regulator NZX Market Supervision says it placed a trading halt on the company pending a response to a price inquiry.
Share price inquiries usually seek information from a company following unusual moves in its shares.
The shares rose 13% today, and have gained 47% this year.